MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1,019 Cr | ₹89 Cr | ₹48 Cr | ₹83 Cr | ₹35 Cr |
What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1,019 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹83 Cr |
| Mar2021 | ₹35 Cr |
How is Contingent Liabilities of MANKIND PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,019 Cr | 1,045.33 | |
| Mar2024 | ₹89 Cr | 85.77 | |
| Mar2023 | ₹48 Cr | -41.97 | |
| Mar2022 | ₹83 Cr | 137.32 | |
| Mar2021 | ₹35 Cr | - | |
Compare Contingent Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹89,742.7 Cr | 1.5% | -2.8% | -19.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.5% |
-2.8% |
-19.5% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses